REVB · Revelation Biosciences, Inc.
$1.14
+0.02 (+1.79%)
At close · Aug 7
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company does not anticipate that its current cash and cash equivalents balance will be sufficient to sustain operations within one year after the date that the Company's unaudited condensed financial statements for June 30, 2026 were issued, which raises substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$4.54M
Shares
3.98M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-14 | 3,089 | $0.99 | $3,058 |
| 2026-07-10 | 2,054 | $0.99 | $2,033 |
| 2026-07-06 | 8,334 | $1.08 | $9,001 |
| 2026-07-01 | 309 | $1.03 | $318 |
| 2026-06-30 | 976 | $1.04 | $1,015 |
| 2026-06-29 | 247 | $0.98 | $242 |
| 2026-06-24 | 100 | $1.05 | $105 |
| 2026-06-18 | 5,360 | $1.07 | $5,735 |
| 2026-06-10 | 194 | $1.04 | $202 |
| 2026-06-01 | 130 | $1.10 | $143 |
| 2026-05-19 | 152 | $1.03 | $157 |
| 2026-05-14 | 263 | $1.03 | $271 |
| 2026-05-13 | 479 | $1.04 | $498 |
Showing 1–13 of 13 settlements